Eversept Partners’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,241
Closed -$10.3M 122
2025
Q4
$10.3M Buy
+48,241
New +$9.96M 0.58% 51
2022
Q2
Sell
-417,172
Closed -$49M 82
2022
Q1
$49M Buy
417,172
+13,494
+3% +$1.56M 4.51% 9
2021
Q4
$54.3M Sell
403,678
-41,525
-9% -$6.18M 4.5% 8
2021
Q3
$71M Buy
445,203
+203,429
+84% +$27.8M 5.7% 2
2021
Q2
$31.8M Sell
241,774
-70,093
-22% -$9.34M 2.95% 17
2021
Q1
$40.2M Buy
311,867
+124,824
+67% +$19M 3.29% 9
2020
Q4
$31.2M Buy
187,043
+26,039
+16% +$4.31M 3.75% 9
2020
Q3
$24.8M Sell
161,004
-59,340
-27% -$8.53M 5.59% 4
2020
Q2
$32.6M Sell
220,344
-55,150
-20% -$7.57M 5.38% 6
2020
Q1
$31M Buy
275,494
+72,600
+36% +$9.43M 8.17% 3
2019
Q4
$28.2M Sell
202,894
-33,498
-14% -$3.72M 5.74% 5
2019
Q3
$22.8M Buy
236,392
+99,995
+73% +$11.2M 7.13% 5
2019
Q2
$15.7M Buy
136,397
+33,101
+32% +$3.96M 4.49% 8
2019
Q1
$12.2M Buy
103,296
+88,042
+577% +$7.71M 3.6% 10
2018
Q4
$956K Sell
15,254
-3,800
-20% -$239K 0.53% 35
2018
Q3
$1.35M Sell
19,054
-11,000
-37% -$757K 0.68% 30
2018
Q2
$2M Buy
30,054
+6,000
+25% +$395K 0.98% 27
2018
Q1
$1.57M Buy
24,054
+11,936
+98% +$671K 0.79% 28
2017
Q4
$485K Buy
+12,118
New +$441K 0.32% 37

Other funds holding ASND